Quoin Pharmaceuticals
QNRX
5 hedge funds and large institutions have $10.7K invested in Quoin Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.18% less ownership
Funds ownership: 0.43% → 0.25% (-0.18%)
29% less funds holding
Funds holding: 7 → 5 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
54% less capital invested
Capital invested by funds: $23.4K → $10.7K (-$12.7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$296 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
-$6.62K |
| 2 |
Morgan Stanley
New York
|
-$1.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$249 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
RhumbLine Advisers
Boston,
Massachusetts
| $8.7K | -$249 | -32 | -3% |
|
|
GI
2
GAMMA Investing
Foster City,
California
| $2K | +$296 | +38 | +16% |
|
|
SS
3
SBI Securities
Tokyo,
Japan
| $14 | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $7 | -$1K | -129 | -99% |
|
|
HNB
5
Huntington National Bank
Columbus,
Ohio
| $6 | – | – | – |
|
|
6
Raymond James Financial
St Petersburg,
Florida
| – | -$6.62K | -717 | Closed |
|
|
7
Morgan Stanley
New York
| – | -$1.9K | -206 | Closed |
|
QNRX Hedge Fund Activity: Q3 2025 in Review
5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2025, worth a combined $10.7K — down 54% from $23.4K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of QNRX and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was GAMMA Investing, adding an estimated $296. The largest seller was Raymond James Financial, exiting entirely with an estimated $6.62K sold.
- 5 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q3 2025, down from 7 in Q2 2025.
- Funds reported $10.7K of Quoin Pharmaceuticals stock for Q3 2025, down 54% quarter-over-quarter.
- 0 funds opened new Quoin Pharmaceuticals positions in Q3 2025 and 2 closed out, a net change of -2 holders.
- The largest Quoin Pharmaceuticals buyer in Q3 2025 was GAMMA Investing, an estimated $296 added.
- The largest Quoin Pharmaceuticals seller in Q3 2025 was Raymond James Financial, an estimated $6.62K sold.
Based on aggregated 13F filings for Q3 2025.